Literature DB >> 3546522

Four-year prospective study of homosexual men: correlation of immunologic abnormalities, clinical status, and serology to human immunodeficiency virus.

W el-Sadr, M Marmor, S Zolla-Pazner, R E Stahl, R Lyden, D William, S D'Onofrio, S H Weiss, W C Saxinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3546522     DOI： 10.1093/infdis/155.4.789

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  9 in total

1.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D R Lucey; C S Via; G M Shearer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

2.  Antibodies against the major core protein p24 of human immunodeficiency virus: relation to immunological, clinical and prognostic findings.

Authors:  B O Lindhardt; J Gerstoft; B Hofmann; G Pallesen; L Mathiesen; E Dickmeiss; K Ulrich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

3.  Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes.

Authors:  H Z Bass; J L Fahey; P Nishanian; R Detels; W Cumberland; M Kemeny; S Plaeger
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

Review 4.  Markers predicting progression of human immunodeficiency virus-related disease.

Authors:  C M Tsoukas; N F Bernard
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

5.  Deterioration in immunologic status of human immunodeficiency virus (HIV)-infected homosexual men with lymphadenopathy: prognostic implications.

Authors:  T J Spira; J E Kaplan; R C Holman; L H Bozeman; J K Nicholson; D B Fishbein
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

6.  Recovery of antitumor CD4+ T cell responsiveness, suppressed in the tumor-bearing state, by release from tumor burden.

Authors:  J P Zou; T Nagata; N Yamamoto; S Ono; H Fujiwara; T Hamaoka
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

7.  Using CD4 counts to evaluate the stages and epidemiology of HIV infection in South Carolina public clinic patients.

Authors:  S Luby; J Jones; J Horan
Journal:  Am J Public Health       Date:  1994-03       Impact factor: 9.308

8.  Serological response in patients with chronic asymptomatic human immunodeficiency virus infection.

Authors:  B O Lindhardt; K Ulrich; P Kusk; B Hofmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

9.  Suppression of anti-tumor CD4+ T cell responsiveness in the tumor-bearing state and its recovery in in vitro culture free of tumor burden.

Authors:  T Nagata; J P Zou; N Yamamoto; S Ono; H Fujiwara; T Hamaoka
Journal:  Jpn J Cancer Res       Date:  1993-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.